Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-18

Clinical Trial Update: Vonoprazan in Helicobacter Pylori Treatment an RCT [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial assessing vonoprazan for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED